Quinbolone

Quinbolone

Quinbolone is an anabolic steroid with a unique history and several interesting characteristics. It was developed in the 1960s and is a derivative of nandrolone, one of the most popular anabolic steroids of all time.

History

Quinbolone was first synthesized in the 1960s by the pharmaceutical company Searle Laboratories. It was marketed under the brand name Anabolicum Vister, and was available in both oral and injectable forms. Despite its promising properties, Quinbolone was not a commercial success and was eventually discontinued.

Pharmacology

Quinbolone is a prodrug of boldenone, meaning it is converted into boldenone in the body. Boldenone is a highly anabolic and moderately androgenic steroid, which means it promotes muscle growth while having less of an impact on secondary male sexual characteristics than some other steroids.

Quinbolone itself has no anabolic effects. Instead, it acts as a reservoir for boldenone, slowly releasing the active steroid into the bloodstream over time. This makes it an effective choice for athletes seeking steady, long-term gains in muscle mass and strength.

Side Effects

Like all anabolic steroids, Quinbolone can have serious side effects. These include liver damage, cardiovascular disease, and psychological effects such as aggression and mood swings. It can also cause masculinization in women and premature closure of the growth plates in children.

Legal Status

Quinbolone is classified as a Schedule III controlled substance in the United States, meaning it is illegal to possess without a prescription. It is also banned by most sports organizations, including the International Olympic Committee and the World Anti-Doping Agency.

See Also

• Anabolic steroid
• Nandrolone
• Boldenone
• Prodrug

This article is a stub related to pharmacology. You can help WikiMD by expanding it!